Barriers and Facilitators to Chronic Red Cell Transfusion Therapy in Pediatric Sickle Cell Anemia

被引:2
作者
Schlenz, Alyssa M. [1 ]
Phillips, Shannon M. [2 ]
Mueller, Martina [2 ,3 ]
Melvin, Cathy L. [3 ]
Adams, Robert J. [4 ]
Kanter, Julie [5 ]
机构
[1] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA
[2] Med Univ South Carolina, Coll Nursing, Charleston, SC 29425 USA
[3] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA
[4] Med Univ South Carolina, Dept Neurol, Charleston, SC 29425 USA
[5] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL USA
来源
JOURNAL OF PEDIATRIC HEMATOLOGY-ONCOLOGY NURSING | 2022年 / 39卷 / 04期
关键词
transfusion; sickle cell anemia; qualitative; multilevel ecological model; HEMATOLOGY; 2020; GUIDELINES; AMERICAN SOCIETY; DISEASE; PREVENTION; MANAGEMENT; CHILDREN; CARE;
D O I
10.1177/27527530211073874
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Chronic red cell transfusion (CRCT) therapy is one of a few effective disease-modifying therapies for children with sickle cell anemia (SCA). CRCT is recommended for primary and secondary stroke prevention for at-risk children with SCA and is sometimes used for other disease-related complications. However, CRCT can be resource- and time-intensive for patients/families, providers, and organizations. This study was conducted to provide a comprehensive, multilevel examination of barriers and facilitators to transfusion therapy in children with SCA from health care provider and caregiver perspectives. Methods: A qualitative descriptive approach was used to conduct key informant interviews in a sample of 26 caregivers and 25 providers across the United States. Interviews were analyzed using directed content analysis with the Multilevel Ecological Model of Health as an initial coding framework and the constant comparison method. Results: Ten barrier themes and 10 facilitator themes emerged across all ecological levels. Themes most commonly occurred on the patient and organizational levels. Key barriers themes included Logistical Challenges, Obtaining and Maintaining Venous Access, Alloantibodies/Alloimmunization and Reactions, and Iron Overload and Adherence to Chelation Therapy. Key facilitator themes included Nursing and Non-nursing Staff Support, Positive Child/Family Experiences, Logistical Help and Social Resources, Blood Bank and Access to Blood, and Transfusion-Specific Resources. Discussion: The comprehensive understanding of multilevel barriers and facilitators to transfusion therapy, including the role of nursing, in children with SCA can inform strategies to improve CRCT for patients/families and providers and can also be applied by organizations seeking to implement transfusion services for SCA.
引用
收藏
页码:209 / 220
页数:12
相关论文
共 25 条
[1]   Blood bank management of sickle cell patients at comprehensive sickle cell centers [J].
Afenyi-Annan, Araba ;
Willis, Monte S. ;
Konrad, Thomas R. ;
Lottenberg, Richard .
TRANSFUSION, 2007, 47 (11) :2089-2097
[2]   Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease [J].
Bakshi, Nitya ;
Sinha, Cynthia B. ;
Ross, Diana ;
Khemani, Kirshma ;
Loewenstein, George ;
Krishnamurti, Lakshmanan .
PLOS ONE, 2017, 12 (07)
[3]   Health-related quality of life in children with sickle cell anemia: Impact of blood transfusion therapy [J].
Beverung, Lauren M. ;
Strouse, John J. ;
Hulbert, Monica L. ;
Neville, Kathleen ;
Liem, Robert I. ;
Inusa, Baba ;
Fuh, Beng ;
King, Allison ;
Meier, Emily Riehm ;
Casella, James ;
DeBaun, Michael R. ;
Panepinto, Julie A. .
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (02) :139-143
[4]  
Boateng L, 2013, J BLOOD DISORD TRANS, V4, P148, DOI DOI 10.4172/2155-9864.1000148
[5]   American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support [J].
Chou, Stella T. ;
Alsawas, Mouaz ;
Fasano, Ross M. ;
Field, Joshua J. ;
Hendrickson, Jeanne E. ;
Howard, Jo ;
Kameka, Michelle ;
Kwiatkowski, Janet L. ;
Pirenne, France ;
Shi, Patricia A. ;
Stowell, Sean R. ;
Thein, Swee Lay ;
Westhoff, Connie M. ;
Wong, Trisha E. ;
Akl, Elie A. .
BLOOD ADVANCES, 2020, 4 (02) :327-355
[6]   American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults [J].
DeBaun, M. R. ;
Jordan, L. C. ;
King, A. A. ;
Schatz, J. ;
Vichinsky, E. ;
Fox, C. K. ;
McKinstry, R. C. ;
Telfer, P. ;
Kraut, M. A. ;
Daraz, L. ;
Kirkham, F. J. ;
Murad, M. H. .
BLOOD ADVANCES, 2020, 4 (08) :1554-1588
[7]  
Dye J., 2000, The Qualitative Report, V4, P1, DOI [https://doi.org/10.46743/2160-3715/2000.2090, DOI 10.46743/2160-3715/2000.2090, 10.46743/2160-3715/2000.2090]
[8]   Patient and family experience with chronic transfusion therapy for sickle cell disease: A qualitative study [J].
Hawkins, Lauren M. ;
Sinha, Cynthia B. ;
Ross, Diana ;
Yee, Marianne E. M. ;
Quarmyne, Maa-Ohui ;
Krishnamurti, Lakshmanan ;
Bakshi, Nitya .
BMC PEDIATRICS, 2020, 20 (01)
[9]   A Systematic Review of Barriers and Interventions to Improve Appropriate Use of Therapies for Sickle Cell Disease [J].
Haywood, Carlton, Jr. ;
Beach, Mary Catherine ;
Lanzkron, Sophie ;
Strouse, John J. ;
Wilson, Renee ;
Park, Haeseong ;
Witkop, Catherine ;
Bass, Eric B. ;
Segal, Jodi B. .
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2009, 101 (10) :1022-1033
[10]   Sickle cell disease perceptions of caregivers, adolescent, and adult patients: Barriers and facilitators to medical care adherence [J].
Hoegy, Delphine ;
Guilloux, Ronald ;
Bleyzac, Nathalie ;
Gauthier-Vasserot, Alexandra ;
Cannas, Giovanna ;
Bertrand, Yves ;
Hot, Arnaud ;
Dussart, Claude ;
Janoly-Dumenil, Audrey .
JOURNAL OF ADVANCED NURSING, 2020, 76 (09) :2391-2400